EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

Nadine Mahmoud, Arfa Mustasam, Justin Miller, Alyssa Lakhram, Firas Hatoum, Zachary J Thompson, Youngchul Kim, Gabriel Roman Souza, Jeffrey S Johnson, Houssein Safa, Philippe E Spiess, Jad Chahoud

Journal of the National Comprehensive Cancer Network · 2026-08 · 24 (8)

DOI: 10.6004/jnccn.2026.7025 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2026-08. Verfasst von Nadine Mahmoud und 11 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Internal Medicine, Saint Louis University, St. Louis, MO. Hauptthemen laut MEDLINE: Penile Neoplasms, B7-H1 Antigen, Carcinoma, Squamous Cell, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Penile squamous cell carcinoma (PSCC) is a rare but aggressive malignancy, with up to 40% of patients presenting with nodal metastasis and poor survival in advanced stages. PD-L1 is an immune checkpoint molecule implicated in tumor immune evasion, yet its prognostic relevance in PSCC remains uncertain. This study aimed to synthesize available evidence on PD-L1 expression, prevalence, and its association with survival and lymph node metastasis. Patients and Methods: PubMed, EMBASE, and the Cochrane Library databases were systematically searched for studies published between January 1996 to June 2025. Eligible studies reported PD-L1 expression in tumor tissue and its correlation with overall survival (OS), cancer-specific survival (CSS), or lymph node metastasis (LNM). Hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) were pooled using random-effects models. Study quality and risk of bias were assessed using the Newcastle-Ottawa Scale. The protocol was registered with PROSPERO (CRD42019129410).

Results

Overall, 15 retrospective studies were included (n=1,445), and 57% of tumors were PD-L1–positive (IQR, 44%–66%). Among 796 patients, PD-L1 expression was significantly higher in HPV-negative than HPV-positive tumors (42% vs 13.5%). A total of 8 studies (n=930) evaluated OS, 9 studies (n=1,091) assessed CSS, and 5 studies (n=622) investigated LNM. PD-L1 positivity was associated with reduced OS (HR, 1.52; 95% CI, 1.12–2.05; I 2 =6.8%), reduced CSS (HR, 1.61; 95% CI, 1.16–2.23; I 2 =38.3%), and higher odds of LNM (OR, 2.94; 95% CI, 1.28–6.78; I 2 =57.3%). In meta-regression, HPV adjustment significantly strengthened the CSS association (QM=7.13; P =.008; HR, 2.06; 95% CI, 1.21–3.51), accounting for all observed heterogeneity.

Conclusions

This meta-analysis, representing the largest pooled cohort to date, shows that PD-L1 expression is associated with adverse outcomes and greater tumor aggressiveness in PSCC. These findings support further evaluation of PD-L1 as a prognostic biomarker in PSCC and highlight the need for standardized assessment methods.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Penile NeoplasmsB7-H1 AntigenCarcinoma, Squamous CellBiomarkers, TumorHumansMalePrognosisLymphatic Metastasis

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • 1Department of Internal Medicine, Saint Louis University, St. Louis, MO.
  • 2Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center, Tampa, FL.
  • 3University of South Florida Health Morsani College of Medicine, Tampa, FL.
  • 4Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL.
  • 5Department of Hematology Oncology, Baylor College of Medicine, Houston, TX.
  • 6Department of Genitourinary Oncology, OrlandoHealth Cancer Institute, Orlando, FL.

Zitieren

APA

Mahmoud, N., Mustasam, A., Miller, J., Lakhram, A., Hatoum, F., Thompson, Z. J., Kim, Y., Souza, G. R., Johnson, J. S., Safa, H., Spiess, P. E., & Chahoud, J. (2026). Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Journal of the National Comprehensive Cancer Network, 24(8). https://doi.org/10.6004/jnccn.2026.7025

Vancouver

Mahmoud N, Mustasam A, Miller J, Lakhram A, Hatoum F, Thompson ZJ, et al. Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. Journal of the National Comprehensive Cancer Network. 2026;24(8). doi:10.6004/jnccn.2026.7025

BibTeX
@article{Mahmoud2026,
  author = {Mahmoud, Nadine and Mustasam, Arfa and Miller, Justin and Lakhram, Alyssa and Hatoum, Firas and Thompson, Zachary J and Kim, Youngchul and Souza, Gabriel Roman and Johnson, Jeffrey S and Safa, Houssein and Spiess, Philippe E and Chahoud, Jad},
  title = {Prognostic Role of PD-L1 in Penile Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2026},
  volume = {24},
  number = {8},
  doi = {10.6004/jnccn.2026.7025}
}
Kostenlos starten →